Ropeginterferon alfa-2b
Besremi (ropeginterferon alfa-2b) is an unknown pharmaceutical. Ropeginterferon alfa-2b was first approved as Besremi on 2019-02-15. It has been approved in Europe to treat polycythemia vera.
| Trade Name | Besremi |
|---|---|
| Common Name | Ropeginterferon alfa-2b |
| Indication | polycythemia vera |
| Drug Class | Pegylated compounds |
